Colgate-Palmolive (NYSE:CL) Shares Sold by Sonora Investment Management Group LLC

Sonora Investment Management Group LLC decreased its stake in Colgate-Palmolive (NYSE:CL) by 26.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,629 shares of the company’s stock after selling 945 shares during the period. Sonora Investment Management Group LLC’s holdings in Colgate-Palmolive were worth $239,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CL. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $32,000. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at about $42,000. Synergy Asset Management LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth about $49,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive during the third quarter worth about $53,000. Finally, Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive during the third quarter worth about $64,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $86.64 on Friday. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30. The firm has a 50 day moving average price of $91.52 and a 200 day moving average price of $97.25. The company has a market cap of $70.78 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 3.70 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.27% and a return on equity of 405.81%. During the same quarter in the prior year, the company earned $0.87 earnings per share. Sell-side analysts predict that Colgate-Palmolive will post 3.58 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CL. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research report on Friday, January 17th. UBS Group cut their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. TD Cowen cut their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Piper Sandler cut their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. One analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $102.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.